Related Experiment Videos
Hematoporphyrin derivatives: an oligomeric composition study.
A F Mironov1, A N Nizhnik, A Y Nockel
1M. V. Lomonosov Institute of Fine Chemical Technology, Moscow, U.S.S.R.
Journal of Photochemistry and Photobiology. B, Biology
|January 1, 1990
Summary
Hematoporphyrin derivatives (HpD) and Photofrin II, used in tumor diagnosis and therapy, were analyzed for their oligomeric porphyrin content. Gel chromatography revealed varying amounts of monomer, dimer, and oligomeric porphyrins in these essential diagnostic and therapeutic agents.
Area of Science:
- Biochemistry
- Medical Chemistry
- Oncology
Background:
- Hematoporphyrin derivatives (HpD) and Photofrin II are clinically significant photosensitizers.
- Their efficacy in tumor diagnosis and therapy is linked to their porphyrin composition.
- Understanding the oligomeric state is crucial for optimizing their clinical application.
Purpose of the Study:
- To determine the oligomeric composition of HpD and Photofrin II.
- To investigate the presence of monomer, dimer, and other oligomeric porphyrins.
- To establish a basis for quality control and therapeutic optimization.
Main Methods:
- Gel chromatography was employed as the primary analytical technique.
- Procedures were designed to prevent artifactual porphyrin aggregation during analysis.
- Quantitative analysis of different porphyrin oligomers was performed.
Main Results:
- HpD and Photofrin II exhibit distinct oligomeric profiles.
- Varying quantities of monomeric, dimeric, and higher oligomeric porphyrins were identified.
- The study confirmed the heterogeneous nature of these photosensitizing agents.
Conclusions:
- The oligomeric composition of HpD and Photofrin II is variable.
- Accurate characterization of porphyrin oligomers is essential for consistent therapeutic outcomes.
- Further research into structure-activity relationships of these oligomers is warranted.